Cargando…
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous varia...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000495/ https://www.ncbi.nlm.nih.gov/pubmed/35408618 http://dx.doi.org/10.3390/molecules27072221 |
_version_ | 1784685449552330752 |
---|---|
author | Abas, Abdul Hawil Marfuah, Siti Idroes, Rinaldi Kusumawaty, Diah Fatimawali, Park, Moon Nyeo Siyadatpanah, Abolghasem Alhumaydhi, Fahad A. Mahmud, Shafi Tallei, Trina Ekawati Emran, Talha Bin Kim, Bonglee |
author_facet | Abas, Abdul Hawil Marfuah, Siti Idroes, Rinaldi Kusumawaty, Diah Fatimawali, Park, Moon Nyeo Siyadatpanah, Abolghasem Alhumaydhi, Fahad A. Mahmud, Shafi Tallei, Trina Ekawati Emran, Talha Bin Kim, Bonglee |
author_sort | Abas, Abdul Hawil |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination. |
format | Online Article Text |
id | pubmed-9000495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90004952022-04-12 Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? Abas, Abdul Hawil Marfuah, Siti Idroes, Rinaldi Kusumawaty, Diah Fatimawali, Park, Moon Nyeo Siyadatpanah, Abolghasem Alhumaydhi, Fahad A. Mahmud, Shafi Tallei, Trina Ekawati Emran, Talha Bin Kim, Bonglee Molecules Review The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination. MDPI 2022-03-29 /pmc/articles/PMC9000495/ /pubmed/35408618 http://dx.doi.org/10.3390/molecules27072221 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Abas, Abdul Hawil Marfuah, Siti Idroes, Rinaldi Kusumawaty, Diah Fatimawali, Park, Moon Nyeo Siyadatpanah, Abolghasem Alhumaydhi, Fahad A. Mahmud, Shafi Tallei, Trina Ekawati Emran, Talha Bin Kim, Bonglee Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title | Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title_full | Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title_fullStr | Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title_full_unstemmed | Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title_short | Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? |
title_sort | can the sars-cov-2 omicron variant confer natural immunity against covid-19? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000495/ https://www.ncbi.nlm.nih.gov/pubmed/35408618 http://dx.doi.org/10.3390/molecules27072221 |
work_keys_str_mv | AT abasabdulhawil canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT marfuahsiti canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT idroesrinaldi canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT kusumawatydiah canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT fatimawali canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT parkmoonnyeo canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT siyadatpanahabolghasem canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT alhumaydhifahada canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT mahmudshafi canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT talleitrinaekawati canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT emrantalhabin canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 AT kimbonglee canthesarscov2omicronvariantconfernaturalimmunityagainstcovid19 |